Programmable RNA targeting with the single-protein CRISPR effector Cas7-11.

@article{zcan2021ProgrammableRT,
  title={Programmable RNA targeting with the single-protein CRISPR effector Cas7-11.},
  author={Ahsen {\"O}zcan and Rohan N. Krajeski and Eleonora Ioannidi and Brennan Lee and Apolonia Gardner and Kira S. Makarova and Eugene V. Koonin and Omar O. Abudayyeh and Jonathan S. Gootenberg},
  journal={Nature},
  year={2021}
}
CRISPR-Cas interference is mediated by Cas effector nucleases that are either components of multisubunit complexes-in class 1 CRISPR-Cas systems-or domains of a single protein-in class 2 systems1-3. Here we show that the subtype III-E effector Cas7-11 is a single-protein effector in the class 1 CRISPR-Cas systems originating from the fusion of a putative Cas11 domain and multiple Cas7 subunits that are derived from subtype III-D. Cas7-11 from Desulfonema ishimotonii (DiCas7-11), when expressed… 

Type III-A CRISPR systems as a versatile gene knockdown technology

It is shown that engineered type III-A modules can be programmed using tailored CRISPR RNAs to efficiently knock down gene expression of both coding and non-coding RNAs in vivo and simultaneous degradation of multiple cellular mRNA transcripts can be directed by utilizing aCRISPR array expressing corresponding gene-targeting crRNAs.

Intrinsic RNA targeting constrains the utility of CRISPR-Cas13 systems

It is determined that each Cas13 system has its intrinsic RNA targets in mammalian cells and further raises cautions about intrinsic RNA targeting during Cas13-based basic and therapeutic applications.

Precise Transcript Targeting by CRISPR-Csm Complexes

The results establish the feasibility and efficacy of multi-protein CRISPR-Cas effector complexes as RNA-targeting tools in eukaryotes.

CRISPR/Cas13 effectors have differing extents of off-target effects that limit their utility in eukaryotic cells

It is found that the off-target effects of RxCas13d, a commonly used Cas13 effector, can be as strong as the level of on-target RNA knockdown and the need for caution when designing and interpreting Cas13-based knockdown experiments is highlighted.

RNA-triggered protein cleavage and cell death by the RNA-guided type III-E CRISPR-Cas nuclease-protease complex

Cryo-electron microscopy structures of the Cas7-11–crRNA–Csx29 complex with and without target RNA are reported, and it is demonstrated that target RNA binding induces a conformational change in Csx29 and results in the protease activation.

Negative autoregulation mitigates collateral RNase activity of repeat-targeting CRISPR-Cas13d in mammalian cells

It is argued that thorough assessment of collateral activity is necessary when applying Cas13d in mammalian cells and that implementation of GENO illustrates the advantages of compact and universally robust regulatory systems for Cas-based gene therapies.

The double life of CRISPR-Cas13.

Structural and functional insights into the type III-E CRISPR-Cas immunity

A series of structures of gRAMP-crRNA, either its alone or in complex with target RNA or TPR-CHAT, and Craspase complexed with cognate (CTR) or non-cognate target RNA (NTR) are reported, providing crucial insights into both the catalytic mechanism and immunity mechanism of the type III-E CRISPR-Cas system.

References

SHOWING 1-10 OF 39 REFERENCES

RNA editing with CRISPR-Cas13

A type VI CRISPR-Cas system containing the programmable single-effector RNA-guided ribonuclease Cas13 is profiled in order to engineer a Cas13 ortholog capable of robust knockdown and REPAIR presents a promising RNA-editing platform with broad applicability for research, therapeutics, and biotechnology.

RNA targeting with CRISPR–Cas13

It is demonstrated that the class 2 type VI RNA-guided RNA-targeting CRISPR–Cas effector Cas13a (previously known as C2c2) can be engineered for mammalian cell RNA knockdown and binding and is established as a flexible platform for studying RNA in mammalian cells and therapeutic development.

Direct CRISPR spacer acquisition from RNA by a natural reverse transcriptase–Cas1 fusion protein

The spacer acquisition machinery of the RT-Cas1–containing type III-B CRISPR system in the bacterium Marinomonas mediterranea was characterized, suggesting the possibility of a concerted spacer integration mechanism involving Cas1 integrase activity and the reverse transcription of RNA to DNA.

Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection

It is shown that bacterial C2c2 possesses a unique RNase activity responsible for CRISPR RNA maturation that is distinct from its RNA-activated single-stranded RNA degradation activity.